Sagefield Capital LP Chimerix Inc Transaction History
Sagefield Capital LP
- $751 Million
- Q1 2025
A detailed history of Sagefield Capital LP transactions in Chimerix Inc stock. As of the latest transaction made, Sagefield Capital LP holds 199,200 shares of CMRX stock, worth $1.7 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
199,200Holding current value
$1.7 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
132Shares Held
70MCall Options Held
293KPut Options Held
133K-
Beryl Capital Management LLC Redondo Beach, CA3.93MShares$33.5 Million13.93% of portfolio
-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.77MShares$32.2 Million0.81% of portfolio
-
Alliancebernstein L.P. New York, NY3.7MShares$31.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$31.2 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...